Literature DB >> 9488313

Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.

M Maxwell1, S D Shih, T Galanopoulos, E T Hedley-Whyte, G R Cosgrove.   

Abstract

Meningiomas are primarily benign brain tumors thought to arise through multistep tumorigenesis, involving both the activation of oncogenes and the loss of tumor suppressor genes. The recently isolated neurofibromatosis 2 (NF2) tumor suppressor gene has been found to be mutated in a large proportion of meningiomas. Almost all cases of familial meningioma occur in association with NF2. Familial meningioma in isolation from NF2 (sporadic) is exceedingly rare, with only 14 reports since 1959. The authors report the existence of a family lacking any stigmata of NF2, in which two members had spinal meningiomas. Tumor specimens were subjected to immunocytochemical analysis for the NF2 protein product Merlin, which has been implicated in the tumorigenesis of meningioma. Merlin immunoreactivity was present in both tumor specimens, implying that the NF2 tumor suppressor gene was not deleted in these tumors. This supports the hypothesis that a second tumor suppressor gene locus, other than NF2, acts in the formation of familial sporadic meningioma. The results are discussed in the context of putative oncogenic mechanisms of familial meningiomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488313     DOI: 10.3171/jns.1998.88.3.0562

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

1.  Meningioma: a clinicopathological evaluation.

Authors:  Nasrin Samadi; Seyed Ali Ahmadi
Journal:  Malays J Med Sci       Date:  2007-01

2.  Non-dura based intaspinal clear cell meningioma.

Authors:  Jun Kyeung Ko; Byung Kwan Choi; Won Ho Cho; Chang Hwa Choi
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

3.  Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

Authors:  D G R Evans; C Watson; A King; A J Wallace; M E Baser
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

Review 4.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 5.  Meningiomas and neurofibromatosis.

Authors:  Stéphane Goutagny; Michel Kalamarides
Journal:  J Neurooncol       Date:  2010-08-17       Impact factor: 4.130

6.  Non-dural-based spinal meningioma : the first case report of a fibrous subtype and a review of the literature.

Authors:  Ji Hye Lee; Hong Joo Moon; Joo Han Kim; Youn-Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2014-07-31

7.  Family history of cancer in benign brain tumor subtypes versus gliomas.

Authors:  Quinn T Ostrom; Christopher McCulloh; Yanwen Chen; Karen Devine; Yingli Wolinsky; Perica Davitkov; Sarah Robbins; Rajesh Cherukuri; Ashokkumar Patel; Rajnish Gupta; Mark Cohen; Jaime Vengoechea Barrios; Cathy Brewer; Cathy Schilero; Kathy Smolenski; Mary McGraw; Barbara Denk; Theresa Naska; Frances Laube; Ruth Steele; Dale Greene; Alison Kastl; Susan Bell; Dina Aziz; E A Chiocca; Christopher McPherson; Ronald Warnick; Gene H Barnett; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Front Oncol       Date:  2012-02-28       Impact factor: 6.244

8.  Meningiomatosis restricted to the left cerebral hemisphere with acute clinical deterioration: Case presentation and discussion of treatment options.

Authors:  Victoria Ohla; Christian Scheiwe
Journal:  Surg Neurol Int       Date:  2015-04-20

9.  Intracranial meningioma with leptomeningeal dissemination : retrospective study with review of the literature.

Authors:  Ki-Su Park; Ki-Hong Kim; Seong-Hyun Park; Jeong-Hyun Hwang; Dong-Hyun Lee
Journal:  J Korean Neurosurg Soc       Date:  2015-04-24

10.  Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas.

Authors:  Yiping Shen; Fabio Nunes; Anat Stemmer-Rachamimov; Marianne James; Gayatry Mohapatra; Scott Plotkin; Rebecca A Betensky; David A Engler; Jennifer Roy; Vijaya Ramesh; James F Gusella
Journal:  BMC Med Genomics       Date:  2009-07-09       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.